Alexander Nowak

Stock Analyst at Craig-Hallum

(2.63)
# 2,241
Out of 5,022 analysts
45
Total ratings
44.44%
Success rate
6.38%
Average return

Stocks Rated by Alexander Nowak

CVRx, Inc.
Jan 17, 2025
Maintains: Buy
Price Target: $20$22
Current: $9.30
Upside: +136.56%
Natera
Nov 13, 2024
Maintains: Buy
Price Target: $121$157
Current: $172.81
Upside: -9.15%
Bioventus
Sep 27, 2024
Maintains: Buy
Price Target: $12$17
Current: $6.70
Upside: +153.73%
QuidelOrtho
Sep 5, 2024
Upgrades: Buy
Price Target: $40$57
Current: $26.17
Upside: +117.81%
Celcuity
May 16, 2024
Assumes: Buy
Price Target: $25$27
Current: $46.20
Upside: -41.56%
CareDx
May 1, 2024
Upgrades: Buy
Price Target: $12$15
Current: $14.36
Upside: +4.46%
DiaMedica Therapeutics
Apr 24, 2024
Assumes: Buy
Price Target: $8
Current: $6.85
Upside: +16.79%
Pulmonx
Sep 5, 2023
Initiates: Buy
Price Target: $18
Current: $1.57
Upside: +1,046.50%
Tandem Diabetes Care
Jun 13, 2023
Maintains: Buy
Price Target: $74$50
Current: $14.38
Upside: +247.71%
DarioHealth
May 12, 2023
Maintains: Buy
Price Target: $280$160
Current: $14.38
Upside: +1,012.66%
Downgrades: Hold
Price Target: n/a
Current: $60.56
Upside: -
Downgrades: Hold
Price Target: n/a
Current: $0.91
Upside: -
Initiates: Buy
Price Target: $11
Current: $3.05
Upside: +260.66%
Maintains: Buy
Price Target: $88$110
Current: $59.27
Upside: +85.59%
Downgrades: Sell
Price Target: n/a
Current: $0.44
Upside: -
Initiates: Buy
Price Target: $300
Current: $3.18
Upside: +9,333.96%
Initiates: Buy
Price Target: $28
Current: $9.14
Upside: +206.35%